Head And Neck Cancer Diagnostics Market Size 2024-2028

The head and neck cancer diagnostics market size is estimated to grow by USD 6.30 billion at a CAGR of 13.64% between 2023 and 2028. The market is influenced by several key factors, including the rising incidence of head and neck cancers, a growing geriatric population, and increasing initiatives focused on cancer awareness and treatment. These elements collectively drive demand for advanced medical treatments, diagnostic tools, and supportive care products in the oncology sector. The increasing prevalence of head and neck cancers underscores the need for effective therapies and early detection methods. The growing elderly population contributes to higher healthcare demands and specialized care needs. Additionally, ongoing initiatives aimed at combating cancer enhance research, treatment options, and patient outcomes. Together, these factors contribute to the growth and development of the market, addressing critical healthcare challenges and improving overall patient care.

To control and fight cancer, private and government agencies have several initiatives that help to promote cancer awareness, diagnosis, and treatment. For example, the American Cancer Society, founded in 1913, works to reduce the risk of cancer. Its global health programs include global anti-cancer efforts, focused on preventing cancer, saving lives, and alleviating suffering. Furthermore, the existence of such initiatives that aim to address the global problem of cancer, rather than just covering a specific region, will promote acceptance of cancer diagnoses, including head and neck cancer, and In turn, will drive the growth of the market during the forecast period.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

AbbVie Inc., Accuray Inc., AdDent Inc., Bristol Myers Squibb Co., Canon Inc., Carestream Health Inc., Eli Lilly and Co., Esaote Spa, Flexicare Group Ltd., General Electric Co., Hitachi Ltd., KARL STORZ SE and Co. KG, Koninklijke Philips N.V., Merck KGaA, Olympus Corp., Optim LLC, Shimadzu Corp., Siemens AG, Sumitomo Mitsui Financial Group, and Xoran Technologies LLC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation 

By Diagnostic 

The market share growth by the biopsy and blood tests segment will be significant during the forecast period. A biopsy is a laboratory procedure in which a piece of tissue or cell sample is removed for analysis in a laboratory. A biopsy is done to diagnose cancer. Biopsies to diagnose head and neck cancer include incisional biopsy, fine needle aspiration (FNA) biopsy, and human papillomavirus (HPV) testing.

Get a glance at the market contribution of various segments Download PDF Sample

The biopsy and blood tests segment was valued at USD 1.64 billion in 2018. Blood tests to detect head and neck cancer include liver function tests (LFTs), cell counts, and measuring antibodies to Epstein-Barr virus (EBV). As biopsies and blood tests can be performed even after performing other diagnostic methods, this segment is expected to contribute the largest revenue share to the market during the forecast period.

By End-user 

Head and neck cancer diagnostic products offer a variety of benefits to hospitals and clinics at different levels and in different roles, including driving cost savings by improving patient care and satisfaction, improving point-of-care operations, and enhancing sales performance. In addition, healthcare providers are focused on improving technological capabilities and developing head and neck cancer diagnostic methods that are compatible with remote access devices and mobile phone apps to quickly obtain accurate diagnostic results. Therefore, such factors are expected to drive the growth of the hospital segment in the global head and neck cancer diagnostic methods market during the forecast period.

By Region

For more insights about the market share of various regions Download PDF Sample

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The US is the largest contributor to the region. Many of the established market players in the market are headquartered in the US. This will make cancer diagnostic equipment widely available to address the increasing incidence of head and neck cancer in the US. Furthermore, the presence of established market players, increasing awareness about HPV-related diseases, and the presence of dedicated head and neck cancer treatment programs are expected to drive the growth of the regional market during the forecast period. 

Buy Full Report Now

Market Dynamics and Customer Landscape

The market is advancing with innovations in MRI and PET/CT technologies for precise diagnostic imaging in cancer centers. It plays a critical role in the early detection of oropharyngeal cancer, throat cancer, and other pharyngeal and oral cancers influenced by alcohol and tobacco intake. Diagnostic devices and novel technologies aid radiologists and pathologists in accurate assessments alongside traditional methods like physical exams. Rising healthcare expenditure and personal healthcare spending support investment in chest imaging and diagnostic devices to enhance patient outcomes. The market's growth is driven by increased hospital spending on prescription drugs and dental care, emphasizing the importance of comprehensive diagnostics in combating head and neck cancers effectively. Our researchers analyzed the market research and growth data with 2023  as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Key Market Drivers

Increasing incidences of head and neck cancers is the key factor driving the growth of the market. Head and neck cancers include cancers of the oral cavity, throat (nasopharynx, oropharynx, and hypopharynx), larynx, sinuses, nasal cavities, and salivary glands. As of January 2020, head and neck cancer accounts for approximately 4% of all cancers in the US. In 2020, an estimated 562,328 people were diagnosed with head and neck cancer worldwide.

Furthermore, according to the NHS, around 12,000 people are newly diagnosed with head and neck cancer each year in the UK. Moreover, around 8,300 people are diagnosed with oral cancer each year in the UK, which equates to one in every 50 cancers diagnosed. Due to this high incidence of head and neck cancer, the demand for head and neck cancer diagnosis is expected to increase during the forecast period.

Significant Market Trends

The growing trend of oncology tourism is the primary trend shaping the market growth. Oncology treatment can be very costly. In the US, some diagnostic procedures and treatment courses can be very expensive. When people in the US travel to other countries for medical procedures, they save approximately 70 to 80 percent of the total costs incurred domestically, without compromising the quality of treatment or care. Another factor driving medical tourism is the fact that people diagnosed with or suspected of having cancer do not want to wait long for treatment.

Moreover, the most popular destinations for cancer treatment are Germany, Spain, France, India, and Israel. Germany offers superior technology-based treatments, France has the highest success rate in Europe, and Spain focuses on alternative oncology treatment options. Therefore, the growth trend in oncology tourism is expected to have a positive impact on the demand for cancer diagnostics, including the market during the forecast period.

Major Market Challenges

The potential disadvantages of excise duty on the sale of medical devices is a challenge that affects the growth of the market. Excise taxes raise the price of a product below the full tax amount, and the price burden is shared by producers and consumers. This in turn will limit innovation. According to the Tax Foundation's general equilibrium model, the reinstatement of excise taxes could also cause significant job losses in the medical device industry.

Additionally, most hospitals in the US procure products from manufacturers through GPO at low prices. Therefore, hospitals' bargaining power may make it difficult for manufacturers to pass on the cost burden of this tax. If such tax policies are not abolished, they may pose major challenges to the growth of medical devices and impede the growth of the market during the forecast period. 

Market Customer Landscape

The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.

 Customer Landscape

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Diagnostic Methods Outlook
  • Biopsy and blood tests
  • Imaging
  • Endoscopy
  • Dental diagnostics
• End-user Outlook 
  • Hospitals
  • Specialty clinics
  • Ambulatory surgical centers
  • Others
• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the World (ROW)
    • Australia 
    • Argentina
    • Brazil 

You may also interested in the market reports:

• Head and Neck Cancer Treatment Market: Head and Neck Cancer Treatment Market by Route Of Administration, Therapy and Geography - Forecast and Analysis

• Cancer Diagnostics Market: Cancer Diagnostics Market Analysis North America, Europe, APAC, Rest of World (ROW) - US, Canada, China, Germany, France - Size and Forecast

• India Oncology Market: India Oncology Market by Type and End-user - Forecast and Analysis 

Market Analyst Overview

The market is evolving with advanced CT and thyroid nodule assessment technologies. Companies like GE Healthcare and Viome Life Science with CancerDetect are pioneering in genomic testing, tumor sequencing, and molecular profiling to identify genetic mutations. Despite reimbursement issues, the integration of software technologies and telemedicine is enhancing diagnostic accuracy and accessibility. Skilled physicians utilize physical exam and innovative tools for precise diagnosis. Clinical trial focus on targeted therapy and immunotherapy as effective treatment modes for cancers originating from squamous cells. Addressing factors like sedentary lifestyle and chronic diseases, and implementing robust economic strategies, are crucial for market growth, supporting comprehensive cancer diagnostics and improved patient outcomes.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies